4-(5,6-bis(4-fluorophenyl)-1,2,4-triazin-3-yl)-1H-1,2,4-triazole-5(4H)-thione

ID: ALA5288780

Max Phase: Preclinical

Molecular Formula: C17H10F2N6S

Molecular Weight: 368.37

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Fc1ccc(-c2nnc(-n3cn[nH]c3=S)nc2-c2ccc(F)cc2)cc1

Standard InChI:  InChI=1S/C17H10F2N6S/c18-12-5-1-10(2-6-12)14-15(11-3-7-13(19)8-4-11)22-23-16(21-14)25-9-20-24-17(25)26/h1-9H,(H,24,26)

Standard InChI Key:  BLCDNQFHRAVBPF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    1.0241    0.0142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1991    0.0142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1991   -0.6969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1991   -1.4082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0241   -1.4082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4224   -2.0910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2189   -2.0910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6457   -1.4082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2189   -0.6969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4224   -0.6969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4423   -1.4082    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1991   -2.0910    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9957   -2.0910    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3939   -1.4082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9957   -0.6969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2190   -1.4082    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6742   -0.7538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4466    0.0142    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4423   -0.9814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4423   -1.8064    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6742   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1991    0.6970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1991    1.4082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0241    1.4082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4224    0.6970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4224    2.0910    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  7  6  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
  5 10  1  0
  8 11  1  0
  4 12  1  0
 12 13  2  0
 14 13  1  0
 14 15  2  0
  3 15  1  0
 14 16  1  0
 17 16  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 21 20  2  0
 21 16  1  0
  2 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25  1  1  0
 24 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5288780

    ---

Associated Targets(Human)

CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E (1410 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 368.37Molecular Weight (Monoisotopic): 368.0656AlogP: 3.73#Rotatable Bonds: 3
Polar Surface Area: 72.28Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.27CX Basic pKa: CX LogP: 4.29CX LogD: 3.96
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.56Np Likeness Score: -1.49

References

1. Cascioferro S, Parrino B, Spanò V, Carbone A, Montalbano A, Barraja P, Diana P, Cirrincione G..  (2017)  An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.,  142  [PMID:28851503] [10.1016/j.ejmech.2017.08.009]

Source